Ivacaftor

被引：67

作者：

Davis, Pamela B. ^{[1
]}

Yasothan, Uma ^{[2
]}

Kirkpatrick, Peter

机构：

[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 05期

关键词：

CYSTIC-FIBROSIS; CFTR POTENTIATOR; MUTATION;

D O I：

10.1038/nrd3723

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

First disease-modifying drug approved in the United States for the treatment of cystic fibrosis in patients with a specific mutation in the gene encoding the cystic fibrosis transmembrane conductance regulator.

引用

页码：349 / 350

页数：2

共 7 条

[1] Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
Clancy, J. P.
Rowe, Steven M.
Accurso, Frank J.
Aitken, Moira L.
Amin, Raouf S.
Ashlock, Melissa A.
Ballmann, Manfred
Boyle, Michael P.
Bronsveld, Inez
Campbell, Preston W.
De Boeck, Kris
Donaldson, Scott H.
Dorkin, Henry L.
Dunitz, Jordan M.
Durie, Peter R.
Jain, Manu
Leonard, Anissa
Mccoy, Karen S.
Moss, Richard B.
Pilewski, Joseph M.
Rosenbluth, Daniel B.
Rubenstein, Ronald C.
Schechter, Michael S.
Botfield, Martyn
Ordonez, Claudia L.
Spencer-Green, George T.
Vernillet, Laurent
Wisseh, Steve
Yen, Karl
Konstan, Michael W.
[J]. THORAX, 2012, 67 (01) : 12 - 18
[2] Cystic fibrosis
O'Sullivan, Brian P.
Freedman, Steven D.
[J]. LANCET, 2009, 373 (9678) : 1891 - 1904
[3] A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, Bonnie W.
Davies, Jane
McElvaney, N. Gerard
Tullis, Elizabeth
Bell, Scott C.
Drevinek, Pavel
Griese, Matthias
McKone, Edward F.
Wainwright, Claire E.
Konstan, Michael W.
Moss, Richard
Ratjen, Felix
Sermet-Gaudelus, Isabelle
Rowe, Steven M.
Dong, Qunming
Rodriguez, Sally
Yen, Karl
Ordonez, Claudia
Elborn, J. Stuart
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) : 1663 - 1672
[4] Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Sermet-Gaudelus, Isabelle
De Boeck, Kris
Casimir, Georges J.
Vermeulen, Francois
Leal, Teresinha
Mogenet, Agnes
Roussel, Delphine
Fritsch, Janine
Hanssens, Laurence
Hirawat, Samit
Miller, Nilsen L.
Constantine, Scott
Reha, Allen
Ajayi, Temitayo
Elfring, Gary L.
Miller, Langdon L.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (10) : 1262 - 1272
[5] US Food and Drug Administration, 2012, FDA LAB INF KAL
[6] Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Van Goor, Fredrick
Hadida, Sabine
Grootenhuis, Peter D. J.
Burton, Bill
Cao, Dong
Neuberger, Tim
Turnbull, Amanda
Singh, Ashvani
Joubran, John
Hazlewood, Anna
Zhou, Jinglan
McCartney, Jason
Arumugam, Vijayalaksmi
Decker, Caroline
Yang, Jennifer
Young, Chris
Olson, Eric R.
Wine, Jeffery J.
Frizzell, Raymond A.
Ashlock, Melissa
Negulescu, Paul
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (44) : 18825 - 18830
[7] Ivacaftor potentiation of multiple CFTR channels with gating mutations
Yu, Haihui
Burton, Bill
Huang, Chien-Jung
Worley, Jennings
Cao, Dong
Johnson, James P., Jr.
Urrutia, Art
Joubran, John
Seepersaud, Sheila
Sussky, Katherine
Hoffman, Beth J.
Van Goor, Fredrick
[J]. JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (03) : 237 - 245

← 1 →